NTproBNP is not a good prognostic marker in patients with advanced heart failure on ambulatory levosimendan infusion program
20 May 2023 (13:34 - 14:42)
Organised by: 
Abstract
Slides
About the speaker
Hospital Fernando Fonseca, Lisbon (Portugal)
6 More presentations in this session
Doctor N. Chapet (Montpellier, FR)
Doctor M. ElRefai (Basildon, GB)
Professor H. Sisakian (Yerevan, AM)
Doctor M. Malek-Elikowska (Poznan, PL)
Access the full session
The Event
Heart Failure 2023
20 May 2023
13:34 CET
You may be interested in
Congress Presentation
